NDAC
This article was originally published in The Tan Sheet
Executive Summary
Last scheduled 1999 meeting, Dec. 2-3, has been canceled due to lack of agenda items. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7-8. NDAC last met on July 20 with the Arthritis Advisory Committee to consider the Rx-to-OTC switch of Merck's Flexeril 5 mg (1"The Tan Sheet" July 26, pp. 3-9)